Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy

Dugas-Breit, S.; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kahler, K. C.; Holst, I.; Brekner, A.; Franklin, C.; Sindrilaru, A.; Zimmer, L.; Heinzerling, L.; Utikal, J.; Meier, F.; Bender, A.; Berking, C.; Garbe, C.; Weichenthal, M.; Schadendorf, D.; Hauschild, A.; Gschnell, M.; Mohr, P.; Hassel, J. C.

dc.contributor.author	Forschner, A.
dc.contributor.author	Garbe, C.
dc.date.accessioned	2026-07-30T08:20:07Z
dc.date.available	2026-07-30T08:20:07Z
dc.date.issued	2026
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/181967
dc.language.iso	en	en
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2025.116149
dc.subject.ddc	610	de_DE
dc.title	Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20260422000000_01543
utue.personen.roh	Dugas-Breit, S.
utue.personen.roh	Forschner, A.
utue.personen.roh	Erdmann, M.
utue.personen.roh	Gutzmer, R.
utue.personen.roh	Kahler, K. C.
utue.personen.roh	Holst, I.
utue.personen.roh	Brekner, A.
utue.personen.roh	Franklin, C.
utue.personen.roh	Sindrilaru, A.
utue.personen.roh	Zimmer, L.
utue.personen.roh	Heinzerling, L.
utue.personen.roh	Utikal, J.
utue.personen.roh	Meier, F.
utue.personen.roh	Bender, A.
utue.personen.roh	Berking, C.
utue.personen.roh	Garbe, C.
utue.personen.roh	Weichenthal, M.
utue.personen.roh	Schadendorf, D.
utue.personen.roh	Hauschild, A.
utue.personen.roh	Gschnell, M.
utue.personen.roh	Mohr, P.
utue.personen.roh	Hassel, J. C.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 116149	de_DE
dcterms.isPartOf.ZS-Volume	233	de_DE
utue.fakultaet	04 Medizinische Fakultät